Skip to main content
PMC home page
Gut logoLink to Gut
. 1985 Jun;26(6):625–628. doi: 10.1136/gut.26.6.625

HLA-DR antigens in primary biliary cirrhosis: lack of association.

M F Bassendine, P J Dewar, O F James
PMCID: PMC1432751  PMID: 3859460

Abstract

A study of HLA-DR antigen in 75 patients with primary biliary cirrhosis has been carried out in order to test the hypothesis that genetic factors related to genes controlling immune responses might be important in the pathogenesis of primary biliary cirrhosis. The frequencies of HLA-DR locus antigens was not significantly different from those in 200 normal controls, nor were those of tissue antigens on the A and B loci. No HLA-DR antigen was significantly associated with the appearance of granulomata on liver biopsy (possibly good prognosis) or with raised serum bilirubin (possibly bad prognosis); nor was there any association between any HLA-DR antigen and adverse reactions to D-penicillamine treatment in 17 patients with such adverse reactions. It is concluded that genetic traits related to HLA antigens studied are probably not important in the aetiology of the disease.

Full text

PDF
625

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bown R., Clark M. L., Doniach D. Primary biliary cirrhosis in brothers. Postgrad Med J. 1975 Feb;51(592):110–115. doi: 10.1136/pgmj.51.592.110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Chohan M. R. Primary biliary cirrhosis in twin sisters. Gut. 1973 Mar;14(3):213–214. doi: 10.1136/gut.14.3.213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Christensen E., Crowe J., Doniach D., Popper H., Ranek L., Rodés J., Tygstrup N., Williams R. Clinical pattern and course of disease in primary biliary cirrhosis based on an analysis of 236 patients. Gastroenterology. 1980 Feb;78(2):236–246. [PubMed] [Google Scholar]
  4. Dewar P. J. The role of the laboratory in rheumatology. HLA antigens. Clin Rheum Dis. 1983 Apr;9(1):93–116. [PubMed] [Google Scholar]
  5. Doniach D., Roitt I. M., Walker J. G., Sherlock S. Tissue antibodies in primary biliary cirrhosis, active chronic (lupoid) hepatitis, cryptogenic cirrhosis and other liver diseases and their clinical implications. Clin Exp Immunol. 1966 Jul;1(3):237–262. [PMC free article] [PubMed] [Google Scholar]
  6. Douglas J. G., Finlayson N. D. Are increased individual susceptibility and environmental factors both necessary for the development of primary biliary cirrhosis? Br Med J. 1979 Aug 18;2(6187):419–420. doi: 10.1136/bmj.2.6187.419. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Engleman E. G., McMichael A. J., Batey M. E., McDevitt H. O. A suppressor T cell of the mixed lymphocyte reaction in man specific for the stimulating alloantigen. Evidence that identity at HLA-D between suppressor and responder is required for suppression. J Exp Med. 1978 Jan 1;147(1):137–146. doi: 10.1084/jem.147.1.137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Epstein O., Jain S., Lee R. G., Cook D. G., Boss A. M., Scheuer P. J., Sherlock S. D-penicillamine treatment improves survival in primary biliary cirrhosis. Lancet. 1981 Jun 13;1(8233):1275–1277. doi: 10.1016/s0140-6736(81)92456-9. [DOI] [PubMed] [Google Scholar]
  9. Ercilla G., Parés A., Arriaga F., Bruguera M., Castillo R., Rodés J., Vives J. Primary biliary cirrhosis associated with HLA-DRw3. Tissue Antigens. 1979 Nov;14(5):449–452. doi: 10.1111/j.1399-0039.1979.tb00874.x. [DOI] [PubMed] [Google Scholar]
  10. Feizi T., Naccarato R., Sherlock S., Doniach D. Mitochondrial and other tissue antibodies in relatives of patients with primary biliary cirrhosis. Clin Exp Immunol. 1972 Apr;10(4):609–622. [PMC free article] [PubMed] [Google Scholar]
  11. Galbraith R. M., Eddleston A. L., Smith M. G., Williams R., McSween R. N., Watkinson G., Dick H., Kennedy L. A., Batchelor J. R. Histocompatibility antigens in active chronic hepatitis and primary biliary cirrhosis. Br Med J. 1974 Sep 7;3(5931):604–605. doi: 10.1136/bmj.3.5931.604. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Galbraith R. M., Smith M., Mackenzie R. M., Tee D. E., Doniach D., Williams R. High prevalence of seroimmunologic abnormalities in relatives of patients with active chronic hepatitis or primary biliary cirrhosis. N Engl J Med. 1974 Jan 10;290(2):63–69. doi: 10.1056/NEJM197401102900201. [DOI] [PubMed] [Google Scholar]
  13. Grumet F. C., Payne R. O., Konishi J., Kriss J. P. HL-A antigens as markers for disease susceptibility and autoimmunity in Graves' disease. J Clin Endocrinol Metab. 1974 Dec;39(6):1115–1119. doi: 10.1210/jcem-39-6-1115. [DOI] [PubMed] [Google Scholar]
  14. Hansen G. S., Rubin B., Sørensen S. F., Svejgaard A. Importance of HLA-D antigens for the cooperation between human monocytes and T lymphocytes. Eur J Immunol. 1978 Jul;8(7):520–525. doi: 10.1002/eji.1830080712. [DOI] [PubMed] [Google Scholar]
  15. James O., Macklon A. F., Watson A. J. Primary biliary cirrhosis--a revised clinical spectrum. Lancet. 1981 Jun 13;1(8233):1278–1281. doi: 10.1016/s0140-6736(81)92457-0. [DOI] [PubMed] [Google Scholar]
  16. James S. P., Elson C. O., Jones E. A., Strober W. Abnormal regulation of immunoglobulin synthesis in vitro in primary biliary cirrhosis. Gastroenterology. 1980 Aug;79(2):242–254. [PubMed] [Google Scholar]
  17. Jaup B. H., Zettergren L. S. Familial occurrence of primary biliary cirrhosis associated with hypergammaglobulinemia in descendants: a family study. Gastroenterology. 1980 Mar;78(3):549–555. [PubMed] [Google Scholar]
  18. Lee R. G., Epstein O., Jauregui H., Sherlock S., Scheuer P. J. Granulomas in primary biliary cirrhosis: a prognostic feature. Gastroenterology. 1981 Dec;81(6):983–986. [PubMed] [Google Scholar]
  19. MacSween R. N., Horne C. H., Moffat A. J., Hughes H. M. Serum protein levels in primary biliary cirrhosis. J Clin Pathol. 1972 Sep;25(9):789–792. doi: 10.1136/jcp.25.9.789. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Mackay I. R., Tait B. D. HLA associations with autoimmune-type chronic active hepatitis: identification of B8-DRw3 haplotype by family studies. Gastroenterology. 1980 Jul;79(1):95–98. [PubMed] [Google Scholar]
  21. Matloff D. S., Alpert E., Resnick R. H., Kaplan M. M. A prospective trial of D-penicillamine in primary biliary cirrhosis. N Engl J Med. 1982 Feb 11;306(6):319–326. doi: 10.1056/NEJM198202113060602. [DOI] [PubMed] [Google Scholar]
  22. Mittal K. K., Mickey M. R., Singal D. P., Terasaki P. I. Serotyping for homotransplantation. 18. Refinement of microdroplet lymphocyte cytotoxicity test. Transplantation. 1968 Nov;6(8):913–927. doi: 10.1097/00007890-196811000-00006. [DOI] [PubMed] [Google Scholar]
  23. Miyamori H., Kato Y., Kobayashi K., Hattori N. HLA antigens in Japanese patients with primary biliary cirrhosis and autoimmune hepatitis. Digestion. 1983;26(4):213–217. doi: 10.1159/000198892. [DOI] [PubMed] [Google Scholar]
  24. Parent K., Mitchell P. D. Bacterial variants: etiologic agent in Crohn's disease? Gastroenterology. 1976 Aug;71(2):365–368. [PubMed] [Google Scholar]
  25. Paterson D. C., Carter R. F., Maxwell G. M., Hillier T. M., Ludbrook J., Savage J. P. Electrical bone-growth stimulation in an experimental model of delayed union. Lancet. 1977 Jun 18;1(8025):1278–1281. doi: 10.1016/s0140-6736(77)91318-6. [DOI] [PubMed] [Google Scholar]
  26. Shapiro J. M., Smith H., Schaffner F. Serum bilirubin: a prognostic factor in primary biliary cirrhosis. Gut. 1979 Feb;20(2):137–140. doi: 10.1136/gut.20.2.137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Stastny P. Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. N Engl J Med. 1978 Apr 20;298(16):869–871. doi: 10.1056/NEJM197804202981602. [DOI] [PubMed] [Google Scholar]
  28. Winchester R. J., Wernet P., Kunkel H. G., Dupont B., Jersild C., Fu S. M. Recognition by pregnancy serums of non-HL-A alloantigens selectively expressed on B lymphocytes. J Exp Med. 1975 Apr 1;141(4):924–929. [PMC free article] [PubMed] [Google Scholar]
  29. Wooley P. H., Griffin J., Panayi G. S., Batchelor J. R., Welsh K. I., Gibson T. J. HLA-DR antigens and toxic reaction to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis. N Engl J Med. 1980 Aug 7;303(6):300–302. doi: 10.1056/NEJM198008073030602. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES